IPT1-independent sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant defensin DmAMP1

FEMS Microbiol Lett. 2003 Jun 27;223(2):199-203. doi: 10.1016/S0378-1097(03)00375-6.

Abstract

Both bacterial cyclic lipodepsipeptide syringomycin E and plant defensin DmAMP1 were shown previously to require expression of the yeast gene IPT1 for fungicidal action against Saccharomyces cerevisiae. IPT1 encodes a sphingolipid biosynthetic pathway glycotransferase that produces the terminal sphingolipid mannosyldiinositolphosphoceramide. However, when grown in half-strength potato dextrose medium, an ipt1 deletion mutant of S. cerevisiae was observed to be sensitive to syringomycin E and DmAMP1 and to produce small amounts of mannosyldiinositolphosphoceramide. These results show that the terminal sphingolipid but not IPT1 expression is required for fungicidal activity, and they suggest an IPT1-independent route for mannosyldiinositolphosphoceramide biosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimicrobial Cationic Peptides / pharmacology
  • Culture Media / pharmacology
  • Defensins*
  • Peptides, Cyclic / pharmacology*
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism*
  • Plant Proteins / pharmacology
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / enzymology*
  • Saccharomyces cerevisiae / growth & development
  • Saccharomyces cerevisiae Proteins*
  • Sphingolipids / biosynthesis*

Substances

  • Antimicrobial Cationic Peptides
  • Culture Media
  • Defensins
  • Dm-AMP1 protein, Dahlia merckii
  • Peptides, Cyclic
  • Plant Proteins
  • Saccharomyces cerevisiae Proteins
  • Sphingolipids
  • syringomycin E
  • IPT1 protein, S cerevisiae
  • Phosphotransferases (Alcohol Group Acceptor)